vs

Side-by-side financial comparison of Cellectis S.A. (CLLS) and INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM). Click either name above to swap in a different company.

Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $6.1M, roughly 1.5× INTELLIGENT PROTECTION MANAGEMENT CORP.). On growth, INTELLIGENT PROTECTION MANAGEMENT CORP. posted the faster year-over-year revenue change (2091.6% vs 375.0%).

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.

CLLS vs IPM — Head-to-Head

Bigger by revenue
CLLS
CLLS
1.5× larger
CLLS
$9.5M
$6.1M
IPM
Growing faster (revenue YoY)
IPM
IPM
+1716.6% gap
IPM
2091.6%
375.0%
CLLS

Income Statement — Q2 FY2024 vs Q4 FY2025

Metric
CLLS
CLLS
IPM
IPM
Revenue
$9.5M
$6.1M
Net Profit
$-25.3M
Gross Margin
53.1%
Operating Margin
-181.1%
-13.4%
Net Margin
-265.9%
Revenue YoY
375.0%
2091.6%
Net Profit YoY
-51.9%
EPS (diluted)
$-0.28
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLLS
CLLS
IPM
IPM
Q4 25
$6.1M
Q3 25
$6.2M
Q2 25
$5.7M
Q1 25
$5.5M
Q2 24
$9.5M
Q4 23
$-7.3M
Q3 23
$1.6M
$2.8M
Q2 23
$2.0M
$3.0M
Net Profit
CLLS
CLLS
IPM
IPM
Q4 25
Q3 25
$-1.1M
Q2 25
$-1.1M
Q1 25
$808.5K
Q2 24
$-25.3M
Q4 23
Q3 23
$-17.5M
$-181.6K
Q2 23
$-16.6M
$135.6K
Gross Margin
CLLS
CLLS
IPM
IPM
Q4 25
53.1%
Q3 25
50.7%
Q2 25
50.1%
Q1 25
55.3%
Q2 24
Q4 23
Q3 23
70.1%
Q2 23
97.3%
73.8%
Operating Margin
CLLS
CLLS
IPM
IPM
Q4 25
-13.4%
Q3 25
-23.0%
Q2 25
-19.7%
Q1 25
-24.2%
Q2 24
-181.1%
Q4 23
Q3 23
-1258.1%
-14.1%
Q2 23
-1180.5%
-9.4%
Net Margin
CLLS
CLLS
IPM
IPM
Q4 25
Q3 25
-17.4%
Q2 25
-18.3%
Q1 25
14.7%
Q2 24
-265.9%
Q4 23
Q3 23
-1064.1%
-6.6%
Q2 23
-831.6%
4.6%
EPS (diluted)
CLLS
CLLS
IPM
IPM
Q4 25
$-0.05
Q3 25
$-0.08
Q2 25
$-0.08
Q1 25
$0.06
Q2 24
$-0.28
Q4 23
$-0.03
Q3 23
$-0.31
$-0.02
Q2 23
$-0.20
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLLS
CLLS
IPM
IPM
Cash + ST InvestmentsLiquidity on hand
$149.0M
$5.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$148.6M
$18.2M
Total Assets
$407.1M
$26.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLLS
CLLS
IPM
IPM
Q4 25
$5.6M
Q3 25
$7.3M
Q2 25
$7.3M
Q1 25
$9.7M
Q2 24
$149.0M
Q4 23
$13.6M
Q3 23
$13.7M
Q2 23
$84.4M
$13.7M
Stockholders' Equity
CLLS
CLLS
IPM
IPM
Q4 25
$18.2M
Q3 25
$18.8M
Q2 25
$19.9M
Q1 25
$21.1M
Q2 24
$148.6M
Q4 23
$20.1M
Q3 23
$76.1M
$20.4M
Q2 23
$96.6M
$20.5M
Total Assets
CLLS
CLLS
IPM
IPM
Q4 25
$26.0M
Q3 25
$27.2M
Q2 25
$29.8M
Q1 25
$31.1M
Q2 24
$407.1M
Q4 23
$23.9M
Q3 23
$209.7M
$24.1M
Q2 23
$227.7M
$24.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLLS
CLLS
IPM
IPM
Operating Cash FlowLast quarter
$28.9M
$87.6K
Free Cash FlowOCF − Capex
$27.6M
FCF MarginFCF / Revenue
290.5%
Capex IntensityCapex / Revenue
13.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLLS
CLLS
IPM
IPM
Q4 25
$87.6K
Q3 25
$133.0K
Q2 25
$-888.7K
Q1 25
$1.7M
Q2 24
$28.9M
Q4 23
$-99.0K
Q3 23
$16.1K
Q2 23
$-47.4M
$-193.8K
Free Cash Flow
CLLS
CLLS
IPM
IPM
Q4 25
Q3 25
Q2 25
Q1 25
Q2 24
$27.6M
Q4 23
Q3 23
Q2 23
$-47.9M
FCF Margin
CLLS
CLLS
IPM
IPM
Q4 25
Q3 25
Q2 25
Q1 25
Q2 24
290.5%
Q4 23
Q3 23
Q2 23
-2391.4%
Capex Intensity
CLLS
CLLS
IPM
IPM
Q4 25
Q3 25
0.0%
Q2 25
Q1 25
Q2 24
13.2%
Q4 23
Q3 23
Q2 23
24.1%
Cash Conversion
CLLS
CLLS
IPM
IPM
Q4 25
Q3 25
Q2 25
Q1 25
2.16×
Q2 24
Q4 23
Q3 23
Q2 23
-1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLLS
CLLS

Segment breakdown not available.

IPM
IPM

Procurement Revenue$5.4M88%
Other$743.9K12%

Related Comparisons